US Patent Issued to Dizal (Jiangsu) Pharmaceutical on June 3 for "Compounds and methods for inhibiting JAK" (British, American Inventors)

ALEXANDRIA, Va., June 4 -- United States Patent no. 12,319,670, issued on June 3, was assigned to Dizal (Jiangsu) Pharmaceutical Co. Ltd. (Wuxi, China).

"Compounds and methods for inhibiting JAK" was invented by James McCabe (Macclesfield, Great Britain), Dedong Wu (Waltham, Mass.), Tudor Grecu (Macclesfield, Great Britain) and Wenzhan Yang (Waltham, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are compounds of formula (I), pharmaceutical compositions comprising such compounds and methods/uses of using the same, for example, for treating a JAK-related disorder, such as cancer, cancer cachexia or an immune disorder:wherein R1 is methyl or ethyl; R2 is selected from methyl, ethyl, methoxy and...